✦ LIBER ✦

Osteoprotegerin and receptor activator of nuclear factor-κB ligand system in the early post-operative period of liver transplantation

✍ Scribed by Emilio Fábrega; Aitor Orive; Maite García-Unzueta; Jose Antonio Amado; Fernanado Casafont; Fernando Pons-Romero

Book ID: 110889677
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 108 KB
Volume: 20
Category: Article
ISSN: 0902-0063
DOI: 10.1111/j.1399-0012.2006.00497.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Circulating profiles of osteoprotegerin

Circulating profiles of osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in post-menopausal women

✍ Uemura, H.; Yasui, T.; Miyatani, Y.; Yamada, M.; Hiyoshi, M.; Arisawa, K.; Iraha 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 95 KB

Receptor activator of nuclear factor κB

Receptor activator of nuclear factor κB ligand and osteoprotegerin in men with thyroid cancer

✍ P. Mikosch; I. Igerc; S. Kudlacek; W. Woloszczuk; H. J. Gallowitsch; E. Kresnik; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

Role of receptor activator of nuclear fa

Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology

✍ Lorenz C. Hofbauer; Armin E. Heufelder 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 119 KB

Expression of the receptor activator for

Expression of the receptor activator for nuclear factor-κB ligand and osteoprotegerin in chronic otitis media

✍ Jerzy Kuczkowski; Monika Sakowicz-Burkiewicz; Ewa Iżycka-Świeszewska 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 729 KB

Differential expression of receptor acti

Differential expression of receptor activator of nuclear factor-κB ligand and osteoprotegerin mRNA in periodontal diseases

✍ N. Bostancı; T. İlgenli; G. Emingil; B. Afacan; B. Han; H. Töz; A. Berdeli; G. A 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

Plasma levels of receptor activator of n

Plasma levels of receptor activator of nuclear factor-κB ligand and osteoprotegerin in patients with neuroblastoma

✍ Donatella Granchi; Alberto Garaventa; Ilaria Amato; Paolo Paolucci; Nicola Baldi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 141 KB

## Abstract Earlier reports showed that the balance between receptor activator of nuclear factor‐κB ligand (RANKL) and its decoy‐receptor osteoprotegerin (OPG) plays an important role in the pathogenesis of metastatic osteolysis induced by neuroblastoma cells. In this study, we investigated whether